U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07829471) titled 'Impact of Routine Electronic Patient-Reported Outcome (ePRO)Symptom Monitoring During Neoadjuvant Therapy in Patients withPancreatic Adenocarcinoma on Patient Experience and ClinicalOutcomes: A Prospective Pre-Post Implementation Study' on Sept. 17.
Brief Summary: To learn if routine symptom monitoring using questionnaires during chemotherapy and/or radiation therapy in patients with PDAC improves patient health-related quality of life and experience with care.
Study Start Date: Feb. 21, 2027
Study Type: INTERVENTIONAL
Condition:
ePRO
Symptom Monitoring
Neoadjuvant Therapy
Pancreatic Adenocarcinoma
Clinical Outcomes
Interventi...